Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Gracyasz (Strasbourg, France), K. Vallière (Strasbourg, France), A. El Habhab (Strasbourg, France), B. Renaud-Picard (Strasbourg, France), F. El-Ghazouani (Strasbourg, France), L. Kessler (Strasbourg, France), F. Toti (Strasbourg, France), R. Kessler (Strasbourg, France). Impact of Tacrolimus in the epithelial-mesenchymal transition in chronic lung allograft dysfonction. 2358

Member's Comments

No comment yet.

Related content which might interest you: Epithelial-mesenchymal transition in chronic lung allograft dysfunction. Role of leucocyte microparticles Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms Year: 2016 Bronchiolitis obliterans formation by epithelial-mesenchymal transition in lung transplant recipients Source: Annual Congress 2010 - Epithelial cells: cell biology and role in lung disease Year: 2010 Evaluation of lung mechanics and the progression of disease in acute allograft rejection after lung transplantation Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation Year: 2010 A role for the mesothelium in restrictive chronic lung allograft dysfunction? Source: International Congress 2017 – The ongoing struggle: insights into chronic lung allograft dysfunction (CLAD) Year: 2017 Pathophysiology of the lung allograft: pathways of graft rejection Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients Year: 2005 Electronic nose for detecting chronic lung allograft dysfunction in lung transplant recipients Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward? Year: 2021 Pronounced neutrophil-rich inflammation in induced sputum of lung transplant recipients with chronic rejection Source: Eur Respir J 2001; 18: Suppl. 33, 297s Year: 2001 Pirfenidone stabilizes pulmonary function and reduces 18F-FDG-uptake in restrictive allograft syndrome following lung transplantation Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment Year: 2014 A model of chronic lung allograft rejection in the rat Source: Eur Respir J 2010; 35: 1354-1363 Year: 2010 Assessment of the restrictive allograft syndrome in patients after lung transplantation Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients Year: 2012 Mycophenolate mofetil reduces alveolar inflammation and acute rejection and improves overall outcome after lung transplantation Source: Eur Respir J 2006; 28: Suppl. 50, 724s Year: 2006 Aerosolized liposomal cyclosporine A for treatment of progressive allograft dysfunction following lung transplantation Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 A new biomarker for chronic lung allograft dysfunction Source: International Congress 2014 – Chronic lung allograft dysfunction: mechanisms, predictors and phenotypes Year: 2014 Impact of mycophenolate mofetil on lung function in chronic hypersensitivity pneumonitis and connective tissue disease related-ILD Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause Year: 2020 Rapamycin in patients with chronic lung rejection Source: Eur Respir J 2005; 26: Suppl. 49, 635s Year: 2005 A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation Source: Eur Respir J 2011; 37: 164-172 Year: 2011 Lung transplantation in rare lung diseases: the problem of chronic lung allograft dysfunction (CLAD) Source: International Congress 2018 – Rare lung diseases Year: 2018 Anti-reflux surgery for gastroesophageal reflux disease after lung transplantation: Benefit for lung function, acute rejections and respiratory infections Source: International Congress 2015 – Outcomes of lung transplantation Year: 2015 KL-6 in serum as a biomarker for differentiation of chronic allograft dysfuntion in lung transplant. Preliminary results Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 Long-term kinetics of CD19+CD24highCD38highBreg cells in lung transplant recipients Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms Year: 2016